China News
-
China | News | 0 Comment | 10 Feb, 2023
China-based Taimei Technology, a digital cooperation platform for the life science industry, has announced the open...Read more
-
Zhongchao Inc. announces introduction of Indian anti-influenza drugs in China
China | News | 0 Comment | 08 Feb, 2023
Zhongchao Inc. has obtained the general distribution rights in Mainland China for anti-influenza drug from Indian pharma...Read more
-
China approves AI software to assess symptoms of Parkinson's disease
China | News | 2 Comment | 03 Feb, 2023
Chinese startup NERVTEX's MoDAS (Movement Dysfunction Assessment Software) system, which is a First-in-Class Artificial ...Read more
-
China-based startup CARsgen partners with Roche for gastric cancer treatment
China | News | 1 Comment | 02 Feb, 2023
CARsgen Therapeutics Holdings, a biopharmaceutical startup based in the US and China, has announced collaboration agreem...Read more
-
Daewoong inks $336 M deal with CS Pharma for Idiopathic Pulmonary Fibrosis treatment in China
China | News | 2 Comment | 01 Feb, 2023
South Korea's Daewoong Pharmaceutical has secured an exclusive licensing agreement with CS Pharmaceuticals, a UK based m...Read more
-
Duoning sets up global HQ and R&D centre at Fengxian Biotechnology Park in China
China | News | 1 Comment | 31 Jan, 2023
Shanghai Duoning Biotechnology Co. has signed an agreement on the Transfer of the Right to Use State-owned Construc...Read more
-
Hong Kong-based startup PanopticAI secures fundraising to digitise remote healthcare
China | News | 0 Comment | 30 Jan, 2023
PanopticAI, Hong Kong's leading health and wellness monitoring startup, has announced a deal closing on a seed...Read more
-
GenScript ProBio completes nearly $220 M Series C Round of financing in China
China | News | 1 Comment | 27 Jan, 2023
GenScript ProBio, a subsidiary of GenScript Biotech Corporation, has announced its Series C round of financing of n...Read more
-
China-based startup ReLive Biotechnologies strengthens presence in regenerative therapy market
China | News | 0 Comment | 26 Jan, 2023
ReLive Biotechnologies, founded in 2021, has completed the acquisition of all operating assets of Germany-listed bi...Read more
-
Hong Kong Science and Technology Parks Corp inks strategic collaboration with Roche
China | News | 0 Comment | 19 Jan, 2023
Hong Kong Science and Technology Parks (HKSTP) Corporation has announced a strategic collaboration with Roche, one of th...Read more
-
Chiome Bioscience terminates oncology agreement with Shanghai Henlius Biotech
China | News | 0 Comment | 23 Jan, 2023
Japan-based Chiome Bioscience has agreed to terminate the License Agreement for anti-TROP-2 antibody ( LIV-20...Read more
-
Asieris Pharma appoints Dr Linda Wu as Chief Development Officer
China | News | 0 Comment | 19 Jan, 2023
Asieris Pharmaceuticals, a China-based biopharma company specialising in discovering, developing and commercialising inn...Read more
-
Hong Kong to emerge as technology hub for microbiome industry in APAC region
China | News | 0 Comment | 18 Jan, 2023
The Faculty of Medicine of The Chinese University of Hong Kong (CU Medicine), Microbiota I-Center (MagIC), and Hong Kong...Read more
-
Amcor expands healthcare platform in APAC with acquisition of China-based MDK
China | News | 0 Comment | 17 Jan, 2023
Amcor, a Switzerland-headquartered firm that develops and produces responsible packaging solutions, has entered into an ...Read more
-
China approves first and only therapy available for patients with EGFR Exon20 Insertion+ NSCLC
China | News | 0 Comment | 12 Jan, 2023
Japan headquatered Takeda's EXKIVITY (mobocertinib) has been approved by the National Medical Products Administration (N...Read more
-
Hong Kong study identifies more cases of primary brain cancer in high-income countries
China | News | 0 Comment | 11 Jan, 2023
Primary brain cancer, though not a common malignancy, has a very poor survival rate compared to other types of cancer; m...Read more
-
Aurisco collaborates with Cytiva to build first Oligo FlexFactory in China
China | News | 1 Comment | 09 Jan, 2023
Aurisco, an innovative pharmaceutical company and CDMO (contract development and manufacturing organisation) in China, i...Read more
-
WuXi Biologics, GSK ink $1.46 B deal for multiple novel bi- & multi-specific T cell engagers
China | News | 0 Comment | 05 Jan, 2023
China-based WuXi Biologics, a leading global Contract Research, Development, and Manufacturing Organisation (CRDMO), has...Read more
